Announcements and company news from Immunomatics. For interviews, data, or additional materials, reach us at press@immunomatics.com.
Experienced transplant diagnostics entrepreneur adds strategic backing and industry guidance to Immunomatics and its AI-based approach to transplant donor risk assessment
Read the release →Audience selects Immunomatics for the SuperCrowd Award following live pitch
Read the release →Transplant survivor-founded healthtech company will present its AI-powered approach to transplant donor risk assessment during the September 30 live pitch event.
Read the release →We are hosting a live webinar to introduce Immunomatics and answer your questions!
Read the release →Medical device regulatory and quality expert joins Immunomatics as the company prepares to advance its AI-powered transplant donor-recipient risk assessment technology toward clinical use.
Read the release →Angel investment adds momentum to Immunomatics’ equity crowdfunding campaign and brings support from an experienced computational biology leader
Read the release →NIH-funded startup founded by a transplant survivor opens investment to the public, with a mission to reduce organ and blood stem cell transplant rejection through precision donor-recipient compatibility scoring.
Read the release →